Leaving the study early · schizophrenia or related disorders
Avatar Therapy showed no clear difference in leaving study early: for any reason compared with treatment (low certainty).
1 finding from 1 review
Spoken communication Measured by: Mullen Scale of Early Learning: Expressive Language Index (MSEL: log (base 2) transformed age equivalent scores) · minimally verbal children with autism spectrum disorder
1 finding from 1 review
Behaviour: Leaving the study early (short‐term) · depression in adults
Music therapy showed no clear difference in leaving the study early Up to 3 months compared with psychological treatment (moderate certainty).
1 finding from 1 review
Early toxicity ‐ not reported · high‐risk neuroblastoma patients treated with autologous HSCT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Early postoperative mortality Deaths in the 30 days after surgery · patients with refractory angina
Transmyocardial laser revascularization showed no clear difference in early postoperative mortality Deaths in the 30 days after surgery compared with medical treatment (high certainty).
1 finding from 1 review
Leaving the study early · patients with schizophrenia
SUPPORTIVE THERAPY showed no clear difference in leaving the study early compared with ANY OTHER PSYCHOLOGICAL OR PSYCHOSOCIAL TREATMENT (moderate certainty).
1 finding from 1 review
Adverse effects: Leaving the study early · patients with schizophrenia
It is very uncertain whether TEMPOROPARIETAL TMS changes adverse effects: Leaving the study early compared with STANDARD TREATMENT (very low certainty).
1 finding from 1 review
Leaving the study early ‐ medium term ‐ not reported · patients with SCHIZOPHRENIA AND CANNABIS USE
The review found no eligible studies for this question.
1 finding from 1 review
Early neonatal sepsis · women with management of intra‐amniotic infection
It is very uncertain whether intrapartum changes early neonatal sepsis compared with postpartum treatment (very low certainty).
1 finding from 1 review
Adverse events: number of treatment related adverse events · adolescents and adults with cystic fibrosis
1 finding from 1 review
Safety of systemic therapies for the treatment of AIMSS · health problem or population
1 finding from 1 review
Failed treatment defined as the need for mechanical ventilation · preterm infants
Prophylactic CPAP probably leads to lower failed treatment defined as the need for mechanical ventilation compared with mechanical ventilation (moderate certainty).
1 finding from 1 review
Maternal death · pregnant women at increased risk of VTE during pregnancy and the early postnatal period
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptomatic thromboembolic events ( · pregnant women at increased risk of VTE during pregnancy and the early postnatal period
It is very uncertain whether antenatal (± postnatal) prophylaxis: heparin (LMWH or UFH) changes symptomatic thromboembolic events ( compared with no treatment/placebo (very low certainty).
1 finding from 1 review
Adverse effects sufficient to stop treatment · women giving birth by elective or emergency caesarean (elective or emergency (1 trial), elective cesarean only (1 trial),…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maternal death · women at increased risk of VTE in the early postpartum period
1 finding from 1 review
Symptomatic thromboembolic events ( · women at increased risk of VTE in the early postpartum period
1 finding from 1 review
Symptomatic PE · women at increased risk of VTE in the early postpartum period
1 finding from 1 review
Symptomatic DVT · women at increased risk of VTE in the early postpartum period
1 finding from 1 review
Symptomatic PE · pregnant women at increased risk of VTE during pregnancy and the early postnatal period
It is very uncertain whether antenatal (± postnatal) prophylaxis: heparin (LMWH or UFH) changes symptomatic PE ( compared with no treatment/placebo (very low certainty).
1 finding from 1 review